Sponsors / TYRA
TYRA

Tyra Biosciences, Inc

Company identity checked against sources

Browse linked trials and recorded changes, or follow this company for updates.

Follow company
3Trials in this database
1Recorded changes · last 12 months
Partial coverageOnly the trials and history collected so far

Research sample: selected versions from May 2023 onward plus a preceding baseline where available. Only selected fields were retained; endpoint measures were truncated to 300 characters. This is not complete trial or sponsor history. Daily snapshots begin when collection starts.

Completion dates · Pro

Which trial dates moved later?

Pro summarizes how far estimated completion dates moved later and counts trials with edits to their main study measures, using the history available here. View Pro features

Included trials

Check company identity source
TrialSponsorPhaseStatusPrimary completion
A Study of TYRA-300 in Children With Achondroplasia: BEACH301NCT06842355TYRAPhase 2Recruiting2030-01Estimated
Efficacy and Safety of TYRA-300 in Participants With FGFR3 Altered Low Grade, Intermediate Risk Non-Muscle Invasive Bladder CancerNCT06995677TYRAPhase 2Recruiting2028-02Estimated
Phase 2A/B Efficacy and Safety of Dabogratinib in Participants With Low Grade Upper Tract Urothelial CarcinomaNCT07265947TYRAPhase 2Recruiting2030-10Estimated

Latest recorded trial changes